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Abstract  Bovine  coronavirus  (BCoV)  is  a  viral  enteric  pathogen  associated  with  calf  diarrhea
worldwide  being,  in Argentina,  mostly  detected  in  dairy  husbandry  systems.  The  aim  of  the
present  work  was  to  study  if  maternal  IgG1  antibodies  (Abs)  to  BCoV  acquired  by  colostrum
intake modulate  the  development  of  BCoV  infection  in  calves  reared  in  a  dairy  farm  in Argentina.
Thirty Holstein  calves  were  monitored  during  their  first  60  days  of age.  Animals  were  classi-
fied into  two groups  depending  on their  initial  BCoV  IgG1  Ab titers.  The  ‘‘failure  of  passive
transfer’’  (FPT)  group  had  significantly  lower  IgG1  Abs  to  BCoV  than  the  ‘‘acceptable
passive transfer’’  (APT)  group  of  calves  (log10  1.98  vs.  3.38  respectively)  (p  < 0.0001).  These
differences  were  also  observed  when  the  total  protein  levels  in both  groups  were  compared
(p = 0.0081).  Moreover,  71%  (5/7)  of  calves  from  the  FPT  group  showed  IgG1 seroconversion  to
BCoV compared  to  29.4%  (5/17)  of  animals  from the  APT  group.  Regarding  viral  circulation,
BCoV was  detected  in 10%  (3/30)  of  all calves  and  BCoV  IgG1  Ab  seroconversion  was  detected
in 42%  of  the total  animals  showing  that  almost  half  of  the  calves  were  infected  with  BCoV.  In
conclusion,  calves  with  high  titers  of  specific  BCoV  IgG1  (≥1024)  were  mostly  protected  against
viral infection,  while  animals  with  low  titers  of  IgG1  (<1024)  were  mostly  infected  with  BCoV.
IgG1 Abs  from  colostrum  origin  are  critical  for  prevention  of BCoV  infection.
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Inmunidad  pasiva  en  el  control  de  la diarrea  por  coronavirus  bovino  en  un rodeo
lechero  de Argentina
Resumen  El coronavirus  bovino  (Bovine  coronavirus, BCoV)  es  un enteropatógeno  viral  aso-
ciado a  la  diarrea  neonatal  del ternero.  El objetivo  del  presente  trabajo  fue  estudiar  si  los
anticuerpos  IgG1  anti-BCoV  adquiridos  pasivamente  mediante  el  calostro  modulan  la  infección
por BCoV  en  terneros  de un  rodeo  lechero  de Argentina.  Se  monitorearon  30  terneros  raza
Holstein durante  los  primeros  60  días  de  vida.  Estos  animales  fueron  clasificados  en  dos  grupos
según sus  niveles  de IgG1 anti-BCoV  maternales:  grupo  con  transferencia  de  inmunidad  pasiva
aceptable (APT)  y  grupo  con  fallas  en  la  transferencia  pasiva  (FPT).  Este  último  grupo  tenía  un
título de  IgG1  significativamente  menor  comparado  con  el  primer  grupo  (log10  1,98  vs.  3,38,
respectivamente;  p  <  0,0001).  La  misma  diferencia  se  observó  cuando  se  compararon  los  niveles
de proteínas  séricas  totales  (p  = 0,0081).  Además,  el  71%  (5/7)  de los  terneros  del  grupo  FPT
mostró seroconversión  de IgG1,  mientras  que  el 29,4%  (5/17)  de los  terneros  del  grupo  APT  la
mostró. Con  respecto  a  la  circulación  viral,  se  detectó  BCoV  en  el  10%  (3/30)  de  los  terneros
así como  también  seroconversión  de  IgG1  en  el 42%  del total de  los  animales,  lo  que  evidencia
que aproximadamente  la  mitad de los terneros  se  infectaron  con  BCoV.  Este  estudio  mostró  que
los terneros  con  altos  títulos  de IgG1  específica  (≥  1.024)  estuvieron  mayormente  protegidos
contra la  infección  con  BCoV,  mientras  que  los  animales  con  títulos  bajos  de  IgG1  (< 1.024)
estuvieron  predispuestos  a  la  infección.  Esto  confirma  que  los anticuerpos  IgG1  calostrales  son
críticos para  la  prevención  de  la  infección  por  este  agente  viral.
© 2017  Asociacio´n  Argentina  de Microbiolog´ıa.  Publicado  por  Elsevier  Espan˜a,  S.L.U.  Este  es  un
art´ıculo Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
Introduction
Bovine  coronavirus  (BCoV)  is  a  major  viral  pathogen  associ-
ated  with  neonatal  calf  diarrhea  (NCD)30, winter  dysentery
in  adult  cattle35,  and  respiratory  tract disorders  in cattle  of
all  ages9,15.  In  addition,  it causes  important  economic  losses
to  the  beef  and  dairy  industry  worldwide5,38.
BCoV  is  comprised  of  a  single  stranded,  non-segmented
positive  sense  genomic  RNA,  32  kb  long,  which  asso-
ciates  to  the nucleoprotein  (N)  forming  a nucleocapsid
having  helical  symmetry24. It  belongs  to  the Betacoro-
navirus  genus  cluster  within  the  Coronavirinae  sub-
family,  Coronaviridae  family,  and  the order  Nidovirales
(http://ictvonline.org/virusTaxonomy.asp).  BCoV  has sev-
eral  structural  proteins  which  have  different  functions  in
the  viral  cycle.  Among  them,  the S  protein  is  responsible  for
the  interaction  between  the virus  and  the  cellular  receptor,
also  eliciting  neutralizing  antibodies  (Abs).
BCoV  is  an enteric/respiratory  virus  that  replicates
in  enterocytes  from  the gastrointestinal  tract as  well
as  in  the  epithelium  of the upper  respiratory  tract5.  Although
it  causes  severe  hemorrhagic  diarrhea  which  is  sometimes
fatal  in  young  animals,  the spiral  colon  is the hot  spot  for
viral  replication  in the gastrointestinal  epithelium  leading
to  osmotic  diarrhea17.  Moreover,  BCoV  is  shed both  through
respiratory  and  enteric  secretions  in high  amounts  (1 billion
virus  particles  per  ml of  feces)  for  up  to  14  days23.  Conse-
quently,  BCoV  infection  is  transmitted  by  fecal-oral  or  respi-
ratory  route  and generally  occurs  by  horizontal  transmission
from  the  mother  to  the offspring  or  between  calves14,18.
The  incidence  of BCoV varies  between  15%  and  70%
in  naturally  occurring  outbreaks  worldwide25,27,31.  In  the
Southern  hemisphere,  Al  Mawly  et  al.1 detected  a BCoV
prevalence  of  14%  during  2011  calving  season  in dairy  farms
in New  Zealand.  Additionally,  Stipp  et al.26 and  Lorenzetti37
reported  15.6%  and 33.3%  of  BCoV  PCR-detection  rates  in
diarrheic  calves  from dairy  and  beef  farms  in  Brazil  in  2009
and  2013  respectively.  In  Argentina,  the  BCoV  detection  rate
by  ELISA  was  1.71%  in calves  with  diarrhea,  corresponding
to  5.95%  of the  herds  analyzed  from  1994  to  2010. Addition-
ally,  those  Argentina-specific  strains  were  distantly  related
to  the  Mebus  reference  strain  in a phylogenetic  analysis6,30.
As  previously  suggested,  BCoV  outbreaks  may  occur  in
calves  from  beef  and  dairy  herds28,37.  However,  in a previ-
ous study  conducted  in Argentina,  BCoV  infection  was  mostly
associated  with  diarrhea  in dairy  husbandry  systems6.  This
difference  may  be  due  to  the close  interaction  between
calves  in  dairy  farms, since  these animals  were reared  under
intensive  management  systems  and  fed  milk  replacers  lack-
ing Abs,  in  stark  contrast  with  beef  cattle  farms, where
herds  were reared  under extensive  management  systems
and  calves  were  fed  directly  from  the  dams’  milk  until  they
reached  6 months  of  age4.
Regarding  the  prevalence  of  BCoV,  serological  surveys
indicate  that  approximately  90%  of  the  worldwide  cattle
population  has  Abs  against  BCoV8. However,  Ohlson et  al.31
observed  that  BCoV  Ab-positive  herds  remained  persistently
high  (75--100%)  in Swedish  Southern  regions  compared  with
Northern  regions  where  the  percentage  of  positive  herds
were  lower  (38--80%).  In Argentina,  100%  of  the adult  cattle
population  is  estimated  to  be seropositive  for  Abs  to  CoVB
(Dr.  Parren˜o,  personal  communication).
Colostrum  intake  is  the  natural  and  most  useful  method
to  control  BCoV  calf  diarrhea12.  Because  BCoV-associated
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diarrhea  is an  early  age disease,  the continuous  presence  of
neutralizing  Abs  in  the  intestinal  lumen,  mostly  IgG1  Abs,
seems  to be  essential  for  prevention  of  BCoV  diarrhea9.
Protective  levels  of  BCoV  Abs  in  calves  could  be  achieved
by  vaccination  of  the  pregnant  cows  during  the  last  three
months  of  pregnancy.  Three  commercial  vaccines  are  avail-
able  in  Argentina,  all  of  them  containing  the inactivated
BCoV  Mebus  strain,  which  confers  cross-protection  with
local  circulating  strains6. However,  Ab  transfer  from  the
colostrum  to  the calf  bloodstream  may  fail due  to deficien-
cies  in  the  quality  and  quantity  of colostrum  produced  by  the
dam,  failure  of  colostrum  intake  by  the calf, or  the newborn
physical  condition29.
There  are  few  studies  reporting  the  transference  of
passive  maternal  Abs  from  the dams to  their  calves  via
colostrum  intake  under  field  conditions,  and  its  role  in  the
protection  against  BCoV infection21.  Thus,  the aim  of  the
present  study  was  to  determine  if IgG1  passive  maternal  Abs
to  BCoV  acquired  by  colostrum  intake  modulate  the  develop-
ment  of BCoV  natural  infection  and disease  in calves  reared
in  a  dairy  farm  in Argentina.
Materials and  methods
Experimental  design
Thirty  Holstein  calves  reared  under  an educative,  inten-
sive  dairy  management  system  were  monitored  during their
first  60  days  of age.  Calves  were  reared  tied to  individual
stakes  with no  contact  of  one calf  with  the other. Calves
were  initially  acquired  from  different  farms  with  varying
levels  of  sanitary  status.  Thus,  vaccination  and  colostrum
administration  differed  depending  on  the standard  operat-
ing  procedure  of  each farm.  The  age of  the calves  at the
beginning  of the  study  (upon  arrival  to  the  herd) ranged  from
one  to  ten  days. All  calves  were  fed  with  two  liters  of  milk
replacer  twice  a day and progressive  amounts  of  calf  starter
(AproAgro  S.A., Argentina).  Neither  preventive  antibiotics
nor  anti-parasitic  drugs  were  administered  to the calves.  In
order  to  evaluate  colostrum  intake,  total  serum  protein  lev-
els  for  each  calf  were  measured  by  refractometry  at the
beginning  of the study (0 days).  Additionally,  serum  samples
were  collected  from  each  calf  every  seven  days  to measure
IgG1  Ab  titers  to  BCoV  by  ELISA.  Animals  were  classified  into
two  groups  depending  on  their  initial  BCoV  IgG1  Ab titers.
Calves  with  BCoV  IgG1  Ab titer  ≤  256 (n = 7)  were  assigned
to  the  failure  of passive  transfer  (FPT) group  and animals
with  BCoV  IgG1  Ab  titers  ≥ 1024  (n  =  17)  were  assigned  to
the  acceptable  passive  transfer  (APT)  group.
In  order  to evaluate  the  presence  of  neonatal  diarrhea
in  calves  with  varying  titers  of  colostrum-derived  Abs,  and
to  understand  the  BCoV infection  dynamics  under  field  con-
ditions,  feces  were  collected  daily  from  each  calf  and  a
diarrhea  score  was  recorded  (0 = normal,  1  =  pasty,  2 = semi
liquid,  3 = liquid,  4 =  hemorrhagic;  a  fecal score  of  2  or  higher
was  considered  diarrhea).  Additionally,  we  analyzed  sev-
eral  parameters  associated  with  the  clinical  infection  of  the
calves.  Those  parameters  were  diarrhea  onset  (days  after
the  beginning  of  the experiment),  age  of  calves  at  diar-
rhea  onset,  diarrhea  duration  (in  days)  and  diarrhea  severity
(measured  as  the average  of  the area  under  the curve of
fecal  scores  of each  calve  during  the period  analyzed).
Furthermore,  mortality  and  BCoV  infection  in calves  with
different  levels  of  passive  immunity  was  recorded.
Finally,  all  calves’  weight  was  registered  at  21  days  of
age  and  at the end  of  the study,  at 60  days  of  age.
IgG1  to  BCoV Ab  ELISA
IgG1  Ab titers  to  BCoV  were  measured  using  a double  sand-
wich  ELISA.  Briefly, 96-well  Maxisorp  NUNC  plates  (Thermo
Scientific
®
,  USA)  were  coated  with  100  l  of  guinea  pig
hyperimmune  serum  to BCoV  (1:5000  dilution  in  carbon-
ate/bicarbonate  buffer,  pH 9.6) and  incubated  overnight
(ON)  at  4 ◦C.  Plates  were then  washed  and  blocked  with
10%  non-fat  milk  solution  diluted  in PBS-0.05%  Tween
20. After  incubation  during  1  hour  at  37 ◦C, BCoV Mebus
strain-infected  (107 FFU/ml)  and  mock-infected  HRT-18
supernatants  were  added  as  positive  and  negative  antigens,
respectively.  Serial  4-fold  dilutions  of the serum  samples
were  tested  in duplicate  followed  by  incubation  with  an
HRP-conjugated  commercial  Ab  to  bovine  IgG1  (Bethyl Lab-
oratories,  Inc., USA).  The  reaction  was  developed  using
hydrogen  peroxide  and ABTS  as  substrate/chromogen  sys-
tem  (Sigma  Aldrich,  USA)  and  read  at a wavelength  of  405  nm
(Multiskan  Ex,  Labsystems  Inc.).  The  titer of  each sample
was  expressed  as  the  reciprocal  of  the  highest  serum  dilu-
tion  with  a  corrected  optical  density  (OD405C;  OD405  values
in  the BCoV-coated  wells  minus  OD405 values  in the HRT-18-
coated  wells)  greater  than  the  cut-off  value  of the  assay.
The  cut-off  value  was  established  as  the average  of OD405C
values  of four  blank  wells  (PBS-0.05%  Tween  20) plus  three
standard  deviations  (SD).
BCoV  detection
Fecal  samples  from  calves  were  collected  daily  and stored  at
-20 ◦C  until  viral detection.  The  presence  of  BCoV  antigens
in  the calves’  feces  was  detected  by  an indirect  antigen-
capture ELISA  that  uses monoclonal  Abs  directed  to  the
viral  proteins  HE,  N,  and  S  as  previously  described36.  Virus
shedding  was  confirmed  by  a CCIF  assay  which  detects
Fluorescent  Focus  forming  Units  of BCoV in HRT-18  cell
monolayers  inoculated  with  the fecal samples,  and  devel-
oped  using  a  fluorescent-labeled  anti-BCoV  hyperimmune
serum.
Differential  diagnosis
Calves’  fecal samples  were  also  tested  for Group  A  Rotavirus
(RVA),  which  is  the  most common  causative  agent  of neona-
tal  gastroenteritis.  The  diagnosis  was  performed  using  an
indirect  antigen-capture  ELISA  as previously  reported2,3,11,16.
No  bacterial  or  parasite diagnosis was  performed.
Statistical analysis
Ab  titers  to  BCoV  determined  by  ELISA  were  log10-
transformed  prior  to  the  statistical  analysis.  Negative
samples  at  a  dilution  of 1:4  were  assigned  an arbitrary
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Ab  titer  of 2  for  the calculation  of  geometric  mean  titers
(GMTs).  Statistical  significance  was  assessed  at  p < 0.05  for
all  comparisons.  Statistical  analyses  were  conducted  using
Infostat
®
statistical  software22.
Group  effects  on  the  IgG1  Ab titers  to  BCoV were ana-
lyzed  by  a  general  linear  mixed  statistical  model (GLMM).
The  model  included  two  main  fixed  factors:  group  (APT  and
FPT,  as  between  subjects’  factor)  and  time  (with  six  lev-
els,  as  within  subjects’  factor).  Animals  were  included  in
the  model  as  a  random  factor.  The  Akaike  Information  Cri-
terion  (AIC)  was  used  for choosing  the best-fitting  model  as
a  minimal  adequate  one.  Thus,  the  model  with  the  lowest
AIC  value  was  selected.  The  GLMM  analysis  was  conducted
by  using  the  glmer  function  (lme4  package,  R  Development
Core  Team,  2014).  The  analysis  was  performed  with  R  3.0.3
(R Development  Core  Team,  2014).  Statistical  significance
was  assessed  at p < 0.05  for all  comparisons.
Results
Thirty  Holstein  calves  reared  under  an educative  intensive
dairy  management  system  were  monitored  for  BCoV infec-
tion  during  their  first  60  days  of  age.  Six out of  thirty  (6/30;
20%)  calves  died  because  of additional  causes  other  than
BCoV  diarrhea.
In  order  to  evaluate  colostrum  intake,  total  serum  protein
levels  for  each  calf were  measured  at the beginning  of  the
study.  The  mean  (±SD)  value  of  total  serum  proteins  in  sera
was  7.1  ± 0.9  g/dl.  When  the kinetics  of  the IgG1 Ab  levels
to  BCoV was  evaluated  by  ELISA  for  each individual  calf, we
observed  that  the  IgG1 Ab  titers  to  BCoV  in the  calves’  sera
(representing  colostrum  intake)  were  highly  heterogeneous
on  arrival  to  the  farm  (IgG1  Ab  titers  for  each  calf are  shown
in Table  1).
Calves’  passive  immunity  to  BCoV was  also  analyzed  in
order  to  understand  BCoV  pathogenesis.  Animals  were classi-
fied  into  the FPT  (titers  ≤  256)  and  APT  (titers  ≥  1024)  groups
depending  on  their  initial  BCoV IgG1  ELISA  Ab  titers  (Fig.  1).
The  IgG1  Abs  to  BCoV  significantly  differed  between  groups
depending  on  the time  (GLMM  Group-Time  F(5,120) =  12.17,
p  < 0.0001).  The  FPT group  had  significantly  lower  IgG1  Ab
titers  to BCoV than  the APT  calves  for  up  to  seven  days
after  the beginning  of  the  experiment.  These  significant
differences  were  also  observed  when  measuring  total  pro-
tein  levels  by  refractometry  (Kruskal--Wallis  rank sum test,
p  = 0.0081)  which  is  the preferred  method  used to  measure
colostrum  Abs  transfer  under  field  conditions.  As  expected,
Table  1  IgG1  antibody  titers  to  BCoV
Group  Calf Serum  total
proteins
(g/dl)
0  days  7 days 14  days  21  days  28  days  35  days  SC BCoV
detection
(ELISA)
APT  66  7.0  1024  16  256  1024  1024  1024  Yes  9,  10,  11  days
71 7.8  4096  1024  1024  1024  1024  1024  No No
74 8.4  4096  4096  4096  4096  4096  1024  No No
83 6.8  1024  256  1024  1024  1024  256  No No
610 7.5  1024  4096  16  4096  1024  1024  Yes  No
614 6.2  1024  1024  1024  256  256  256  No No
72 8.4  4096  4096  1024  1024  256  1024  No No
85 7.2  4096  256  1024  1024  1024  64  No No
615 7.8  1024  256  1024  256  256  1024  No No
65 7.5  1024  1024  1024  256  256  256  No No
80 8.6  4096  4096  4096  16  1024  4096  Yes  No
81 6.6  4096  1024  1024  64  4096  1024  Yes  No
84 6.5  1024  1024  256  64  64  64  No No
87 7.8  4096  4096  4096  4096  1024  1024  No No
611 7.0  1024  4096  1024  1024  Dead  15,  16  days
612 6.0  4096  4096  1024  1024  1024  64  No No
613 7.5  4096  4096  4096  1024  1024  256  No No
FPT 77  5.9  256  256  256  256  1024  1024  No No
68 6.8  256  256  64  256  256  1024  Yes  No
76 7.6  64  64  256  65  536 16  384 4096  Yes  6,  7 days
78 5.4  16  16  256  1024  4096  4096  Yes  No
79 6.4  256  256  256  256  256  256  No No
82 5.9  16  256  1024  4096  1024  4096  Yes  No
75 6.4  256  16  256  256  256  1024  Yes  No
APT Log10  average  3.38A 3.15A 2.99A 3.01A 2.86A 2.66B 23.5%  (5/17)A
FPT  Log10  average  1.9C 1.9C 2.41B 2.68B 3.01A 3.18A 71.4%  (5/7)A
BCoV IgG1 Ab titers in serum of each calf measured every seven days. APT: acceptable passive transfer; FPT: failure of passive transfer;
SC: seroconversion; BCoV detection is shown in days of experiment. Means in the same column with different superscript upper case
letters differed significantly (repeated measurements over time ANOVA Test, p  < 0.05).
Document downloaded from http://www.elsevier.es, day 17/06/2018. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.
Passive  immunity  to  bovine  coronavirus  in Argentina  27
1
10
100
1000
10  000
100  000
0 7 14 21 28 35
FPT grou p (n=7) APT group  (n=1 7)
SC: 71%
A
B
Ig
G
1 
a
n
tib
od
y 
tit
er
 
to
 
BC
oV
Days
Figure  1  BCoV  IgG1  Ab  profiles  from  calves  with  acceptable
passive  transfer  (APT)  compared  with  calves  with  failure  of  pas-
sive transfer  (FPT)  during  the  first  35  days  of  life.  Letters  shows
statistically  significant  differences  in  IgG1  Ab  titers  to  BCoV
after colostrum  intake  (p  <  0.0001).  SC:  seroconversion  shows
the percentage  of  animals  infected  with  BCoV  in  the  FPT  group.
the higher  the initial level  of  IgG1  Abs  in the  calves’  sera,
the  longest  it  took  for  them  to  decrease  to  a  susceptible
level.  When  BCoV  IgG1  Ab  titers  decreased  to  16  or  64,  BCoV
infection  was  evidenced  by  either virus  detection  in feces,
or  by  a  minimum  16-fold  increase  of  anti-BCoV  IgG1  ELISA
Ab  titers  for  around  two  weeks  (defined  as  seroconversion
for  the  purpose  of  this  study)  (Table  1,  Fig.  2).  Moreover,
71%  (5/7)  of calves  from  the FPT  group  showed  BCoV  IgG1
seroconversion  between  14  and  21  days  of  the experiment
while  only  29.4%  (5/17)  of  the  animals  from  the APT  group
presented  sequential  seroconversion  during  the  same  period
(Fisher’s  exact  test,  p = 0.085)  (Fig.  1 and  Table  1).  How-
ever,  the  moments  of  seroconversion  in the  different  groups
of  calves  are  not necessarily  correlated  with  the days  of
age  because,  as  we  mentioned  before,  the calves’  age  was
between  1 and  10  days  at the  beginning  of  the experience.
The  APT  group  average  age  at day 0 of  the experience  was
2.8  days  while  the  FPT group  average  age was  5.4  days  (data
not  shown).
Considering  the presence  of neonatal  diarrhea  in calves
with  varying  titers  of  colostrum  Abs,  it  was  observed  that
all  calves  were  affected  by  one,  two  or  even  three  events
of  severe  diarrhea  with  an average  duration  of  18  days
(Table  2);  BCoV  shedding  of  short  time  duration  (2--3  days)
was  detected  in  10%  (3/30)  of  calves  (Tables  1  and  2)  and
the  highest  BCoV infectious  titer  was  105 FFU/ml  of  stool.
Although  viral  shedding  was  detected  at a low  rate  in the
calves’  stool,  BCoV  IgG1  seroconversion  was  observed  in  42%
of  animals,  suggesting  that  almost  half  of  the  calves  were
exposed  to BCoV  (Table 1).
Calves  shedding  BCoV in stools  were  further  analyzed.
Calf  #66  had  a  first  14  day-diarrhea  episode  in  which  BCoV
was  detected  from  9 to  11  days  of  the study  (9,  10  and 11
days  of  age).  This  calf  had  additional  diarrhea  episodes  that
were  not  associated  with  BCoV  infection.  Calf  #76  had  diar-
rhea  since  the  experiment  started  (ten  days  of  life  for  this
calf)  and  during  15  days,  in  which  BCoV  was  detected  at
6  and  7  days  of  the experiment  (15  and  16  days  of age).
Then,  this  calf  had  other  diarrhea  episodes  without etiologic
Table  2  Clinical  parameters  and  BCoV  infection
Number  of  calves  30
Diarrhea  onset  (day  of  experiment)  3.1
Age of  calves  at  diarrhea  onset  7.5
Diarrhea  duration  (days)  18
Diarrhea  severity  33.5
Mortality  20%  (6/30)*
Passive  IgG1  to  BCoV  (GMT) 846.2
BCoV  infection  (SC  and shedding) 42%  (10/24)
Average of clinical parameters from the calves under study.
* Three calves died  because of external factors such as labour
dystocia, septicemia or unknown reason. SC: seroconversion;
GMT: geometric mean titer.
diagnosis.  Finally,  calf  #611  had  16  days  of  severe  diarrhea
beginning  at  day two  of  the  study  (six  days  of  life),  while
BCoV  was  detected  at 15  and  16  days  of  the  experiment  (20
and  21  days  of  age).  In these three  cases  the presence  of
BCoV  was  associated  with  severe  diarrhea  (fecal  score  ≥  3).
Two  out  of  three  calves  showed  BCoV IgG1  seroconversion
at  the same  time  of  viral  detection  (Fig.  2). The  third  BCoV-
positive  calf died with  severe  diarrhea.
Calves’  fecal  samples  were  also  tested  for  RVA  as  another
common  causing  agent  of  neonatal  gastroenteritis.  RVA
shedding  was  detected  in 50%  (15/30)  of the calves,  between
three  to  ten days  of  age.  No  bacterial  or  parasite  diagnosis
was  performed;  however,  taking  into  consideration  that  nei-
ther  antibiotics  nor  anti-parasitic  drugs  were  administered
to the  calves,  diarrhea  caused  by  either  of these  groups  of
agents  may  not be discarded.
As  a  final  important  parameter,  all the calves’  weight  was
registered.  Even  though  all  the  calves  presented  severe  diar-
rhea  at  some  point during  the study,  once  the  clinical  signs
of gastroenteritis  disappeared,  all  animals  gained  weight
reaching  an average  of 90  kg by  the  end  of the  experiment.
All  calves  duplicated  their  weight  during  the study  period
(60  days)  with  no  significant  differences  between  the groups.
Discussion
In  order  to  better  understand  BCoV  infection  and preven-
tion  in calves  reared  under  artificial  management  systems,
30  calves  were  followed  up during  their  first 60 days  of  life  at
an  educative  dairy  farm.  Both, the immunologic  status of the
calves  at birth  and the colostrum  quality  of  the  dams are  the
most  important  factors  influencing  prevention  of  neonatal
calf  diarrhea34.  The  outcome  of  BCoV infection  was  clearly
affected  by  passively  acquired  Abs  from colostrum.  IgG1  sub-
type  is  the main IgG  Ab  isotype  actively  concentrated  during
colostrogenesis19,  and  was  the  isotype  analyzed  in  this  study.
Refractometry  is  the commonly  used method  for  total
protein  measurement  to  evaluate  colostrum  intake  in
calves’ serum.  However,  the exact  titer  of BCoV-specific
IgG1  transferred  to  calves  from  maternal  colostrum
required  to  prevent  BCoV  diarrhea  in  the field  remains
unclear.  Total  protein  level  ≥  5.2  g/dl  (corresponding  with
IgG  ≥  1000  mg/dl)  in serum  from  a healthy  calf  is consid-
ered  to  be  an optimal  level of  protein  transfer39. In  this
study,  we  observed  a mean  protein  level of 7.1  g/dl  which
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Figure  2  Diarrhea  and  Ab responses  in calves  shedding  BCoV.  Each  chart  shows  ELISA  virus shedding,  fecal  score  and  IgG1  Ab  titers
to BCoV  over  time.  Horizontal  bars: BCoV  shedding.
is  optimal;  however,  the FPT  group  had  a  significantly  lower
level  of  total  protein  in serum  than  the APT  group  at day  0
of  the  experiment  (Kruskal--Wallis  non-parametric  rank sum
Test,  p  = 0.0081).  This  correlates  with  the  higher  detection
of  BCoV  IgG1  Ab  seroconversion  in the  FPT group  compared
with  the  APT  animals.
This  study  also  aimed  to  further  define  BCoV  pathogen-
esis,  and  to  better understand  BCoV-specific  Ab kinetics.  In
Argentina,  we  previously  reported  a significantly  higher  rate
of  BCoV  diarrhea  in dairy  herds  compared  to  beef  herds6. We
detected  viral  shedding  in a small number  of  animals  but
high  viral  circulation  manifested  through  BCoV seroconver-
sion.  Low  viral  detection  could  be  due  to  a  lower  sensitivity
of  ELISA  compared  with  the RT-PCR  assay  to detect  BCoV in
feces7.  However,  another  country  from  the southern  hemi-
sphere  shows  a low detection  rate  using  RT-PCR1.  BCoV
shedding  was  detected  at high  titers  during  only  two  or  three
days  differing  with  other  experiments  in  which  BCoV shed-
ding  was  long  lasting23,32.  This  supports  the idea  of  a lower
sensitivity  of the  ELISA  assay  for BCoV  detection  used.  More-
over,  we  showed  that  calves  with  high  BCoV IgG1  Ab  titers
were  often  protected  against  infection,  while  animals  with
low BCoV IgG1  Ab  titers  showed  significantly  higher  BCoV
infection  rates  (p  < 0.0001).  On the  one  hand,  BCoV  infection
dynamics  was  drastically  affected  by  these  Ab  titers  since
71%  of  FPT  animals  showed  BCoV IgG1  seroconversion  dur-
ing the  experiment.  The  significant  difference  in Ab  titers  at
the  beginning  of  the study  was  also  associated  with  a  signif-
icant  difference  in total  protein  levels.  Furthermore,  when
IgG1  titers  decreased  over  time  and  reached  non-protective
levels  (BCoV  IgG1  Ab  titers  of  16  or  64),  calves  seroconverted
confirming  BCoV infection,  even  when  the  antigen  was  not
detected  in  the  feces  by  the methodology  used.  On  the
other  hand,  70.6%  of  animals  from  the APT  group  maintained
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elevated  IgG1  Ab  titers  over  time  and only  five  calves  even-
tually  seroconverted.  Moreover,  calves  with  maternal  BCoV
IgG1  Ab  titers  of  4096  or  higher  seemed  to  be  protected
against  BCoV  infection  over  the  course  of this study,  sug-
gesting  that specific  IgG1  Abs  from  colostrum  are critical
for  the  prevention  of BCoV  infection20.  Although  there  was
a  tendency  to  observe  more  BCoV  IgG1  seroconversion  in
calves  from  the  FPT  group  compared  with  calves  from  the
APT  group,  this  difference  was  not significant  (Fisher’s  Exact
Test,  p  =  0.085).  This  could  be  due  to  a  low number  of  exper-
imental  units  in  the  FPT group.
Weight  gain  was  evaluated  in all  calves  at  the  end  of the
study  (60  days  of  age),  compared  to  baseline  measurements
obtained  at  the beginning  of the study.  No  significant  weight
differences  between  groups  were  observed.  Even  though  we
do  not  have  a negative  control  group  --  animals  with  no  signs
of  diarrhea  --  it has  been  reported  that average  daily  weight
gain  does  not  correlate  with  the occurrence  of  NCD33.  How-
ever,  other  studies  demonstrated  the influence  of  NCD  on
weight  gain  in  beef  calves10.  In  addition,  it  has  also  been
established  that  when  BCoV  is  present  in diarrhea  outbreaks,
it  causes  more  aggressive  clinical  signs  compared  to other
gastrointestinal  viruses,  which  can  compromise  the animal
survival5.  Indeed,  one  of  the  animals  shedding  BCoV  died  due
to  the  severity  of  the diarrhea  during  the course of this  study.
Vaccination  is  the  most  effective  strategy  used  to  prevent
NCD.  However,  vaccination  success  can be  affected  by  sev-
eral factors  including  deficiencies  in herd  management  and
varying  vaccine  quality29. As  was  mentioned  previously,  we
have  no  information  either  about  the vaccination  of  dams
against  neonatal  diarrhea  or  about  the  quality  of  commer-
cial  CoVB  vaccines.  Therefore,  Abs  transferred  to  calves
through  colostrum  intake  might  be  due  to  previous  expo-
sure  to  BCoV  or  to  an active  immunization  of the  dam  with
this  agent.  The  lack  of  a  good passive immune  transference
in  addition  to a diet based on  milk  replacer  might  only have
contributed  to  the  occurrence  of  diarrhea  in 100%  of the
studied  animals.  All  calves  suffered  a severe  and  long  last-
ing  diarrhea  (17  to 19  days).  The  etiology  of diarrhea  could
be  diverse  since  other  infection  agents  were  not discarded,
and  neither  antibiotic  nor  anti-parasitic  drugs  were  used  as
preventive  strategies.  BCoV  infection  was  evidenced  by  anti-
gen  shedding  or  seroconversion  in 42%  of  the calves,  while
RVA  infection  was  evidenced  by  shedding  in 50%  of  calves.
Thus,  RVA  is  a  major  agent  associated  with  NCD,  as  has  been
reported  elsewhere1,2,13.
The  present  study  highlights  the  critical  role  of maternal
colostrum-derived  Abs  in the development  of  BCoV infec-
tion.  The  systematic  immunization  of  cows  with  a vaccine
of  proved  efficacy,  the monitoring  of  colostrum  quality,  and
the  efficient  passive  transfer  to  the calf  are  key  factors to
consider  when  attempting  to  control  BCoV-related  diarrhea.
The  results  displayed  in this study  point  to  useful  end-points
to  measure  when  evaluating  the  potency  and  efficacy  of  a
BCoV  vaccine  under  field  conditions.
Ethical disclosures
Protection  of human  and  animal  subjects.  The  authors
declare  that  no  experiments  were  performed  on  humans  or
animals  for  this  study.
Confidentiality  of data.  The  authors  declare  that no  patient
data  appear  in  this  article.
Right  to  privacy  and  informed  consent.  The  authors
declare  that  no  patient  data  appear  in  this article.
Conflict  of  interest
The  authors  declare  that  they  have  no  conflicts  of  interest.
Acknowledgements
We are very  grateful  for  the  technical  assistance  of
Dr.  Osvaldo  Zábal,  for  the  input  from  the professors  at the
Milk  Production  Department  of Litoral  National  University  in
Argentina,  Dr.  Federico  Guzman  Coraita,  Dr.  Mario  Cabellier,
Dr.  Julieta  Bianchini,  Dr.  Carolina  Repetto,  Dr.  Pilar  Busta-
mante,  Dr.  Alberto  Cabrera,  Leonela  Riera,  Paula  Patricelli,
Corina  Pautasso,  and  their  students.  We  are  also  grateful  to
Dr.  Linda  Saif  for  her  assistance  in  setting  up  the diagnostic
assay,  to  Dr.  Karin  Bok for English  edition and to  Dr.  Karina
Hodara  for statistical  support.  This  study  was  supported  by
funds  from  FONARSEC  N◦ 003 INTABIO  AF, MinCyT,  Argentina.
MB  and  Dr.  VP  are members  of  CONICET.
References
1. Al Mawly J, Grinberg A, Prattley D, Moffat J, French N. Preva-
lence of  endemic enteropathogens of  calves in New Zealand
dairy farms. N  Z  Vet J. 2014;1--18.
2. Badaracco A, Garaicoechea L, Rodríguez D, Louge Uriarte E,
Odeón A, Bilbao G, Galarza R, Abdala A, Fernandez F, Parren˜o
V. Bovine rotavirus strains circulating in beef and dairy herds in
Argentina from 2004 to 2010. Vet Microbiol. 2012;158:394--9.
3. Badaracco A, Garaicoechea L,  Matthijnssens J, Louge Uriarte E,
Odeón A, Bilbao G, Fernandez F,  Parra GI, Parren˜o V. Phyloge-
netic analyses of  typical Bovine rotavirus genotypes G6, G10,
P[5] and P[11] circulating in Argentinean beef and dairy herds.
Infect Genet Evol. 2013;18:18--30.
4. Bendali F,  Sanaa M, Bichet H, Schelcher F. Risk  factors associated
with diarrhoea in newborn calves. Vet Res. 1999;30:509--22.
5. Boileau MJ, Kapil S.  Bovine coronavirus associated syndromes.
Vet Clin North Am Food Anim Pract. 2010;26:123--46.
6. Bok M, Mino  S,  Rodriguez D, Badaracco A, Nunes I,  Souza SP,
Bilbao G, Louge Uriarte E, Galarza R,  Vega C, Odeon A, Saif LJ,
Parren˜o V. Molecular and antigenic characterization of Bovine
coronavirus circulating in Argentinean cattle during 1994--2010.
Vet Microbiol. 2015;181:221--9.
7. Cho KO, Hasoksuz M, Nielsen PR, Chang KO, Lathrop S,
Saif LJ. Crossprotection studies between respiratory and calf
diarrhea and winter dysentery coronavirus strains in  calves
and RT-PCR and nested PCR for their detection. Arch Virol.
2001;146:2401--19.
8. Cho KO, Hoet AE, Loerch SC, Wittum TE, Saif LJ. Evaluation
of  concurrent shedding of  Bovine coronavirus via the respira-
tory tract and enteric route in feedlot cattle. Am J Vet Res.
2001;62:1436--41.
9. Clark MA. Bovine coronavirus. Br Vet J. 1993;149:51--70.
10. Cornaglia EM, Fernández FM, Gottschalk M,  Barrandeguy ME,
Luchelli A, Pasini MI, Saif LJ, Parraud JR, Romat  A, Schudel AA.
Reduction in morbidity due to diarrhea in nursing beef calves by
use of an inactivated oil-adjuvanted rotavirus -- Escherichia coli
vaccine in the dam. Vet Microbiol. 1992;30:191--202.
Document downloaded from http://www.elsevier.es, day 17/06/2018. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.
30  M.  Bok et al.
11. Cornaglia EM, Fitjman N, Schudel AA, Barrandeguy M. Enzyme-
linked immunosorbent assay, immunofluorescent test and
electrophoresis analysis of rotaviral RNA in the diagnosis and
characterization of the Bovine rotavirus.  Rev Latinoam Micro-
biol. 1989;5:6--9.
12. Cortese VS. Neonatal immunology. Vet Clin North Am Food Anim
Pract. 2009;25:221--7.
13. Coura FM, Freitas M, Ribeiro J,  De Leme RA, De Souza, Alfieri
AA, Facury Filho EJ, De Carvalho AU, Silva MX, Lage AP,
Heinemann MB.  Longitudinal study of  Salmonella spp., diar-
rheagenic Escherichia coli, Rotavirus, and Coronavirus isolated
from healthy and diarrheic calves in a Brazilian dairy herd. Trop
Anim Health Prod. 2015;47:3--11.
14. Crouch CF, Acres SD. Prevalence of rotavirus and coronavirus
antigens in the feces of  normal cows. Can J  Comp Med.
1984;48:340--2.
15. Decaro N, Elia G,  Campolo M, Desario C, Mari V, Radogna A,
Colaianni ML, Cirone F,  Tempesta M,  Buonavoglia C. Detection
of Bovine coronavirus using a TaqMan-based real-time RT-PCR
assay. J Virol Methods. 2008;151:167--71.
16. Garaicoechea L, Bok  K, Jones LR, Combessies G, Odeon A,
Fernandez F, Parren˜o V. Molecular characterization of Bovine
rotavirus circulating in beef and dairy herds in Argentina during
a 10-year period (1994--2003). Vet Microbiol. 2006;118:1--11.
17. Gunn AA, Naylor JA, House JK. Diarrhea. Large Anim Intern Med.
2009:340--63.
18. Heckert RA, Saif LJ, Hoblet KH, Agnes AG. A longitudinal study
of Bovine coronavirus enteric and respiratory infections in dairy
calves in two herds in Ohio. Vet Microbiol. 1990;22:187--201.
19. Heckert RA, Saif LJ, Mengel JP,  Myers GW. Isotype-specific
antibody responses to Bovine coronavirus structural proteins
in serum, feces, and mucosal secretions from experimentally
challenge-exposed colostrum-deprived calves. Am J Vet Res.
1991;52:692--9.
20. Heckert RA, Saif LJ, Myers GW.  Mucosal and systemic isotype-
specific antibody responses to Bovine coronavirus structural
proteins in naturally infected dairy calves. Am J  Vet Res.
1991;52:852--7.
21. Heckert RA, Saif LJ, Myers GW, Agnes AG. Epidemiologic fac-
tors and isotype-specific antibody responses in serum and
mucosal secretions of  dairy calves with Bovine coronavirus
respiratory tract and enteric tract infections. Am J  Vet Res.
1991;52:845--51.
22. Di Rienzo JA, Casanoves F, Balzarini MG, Gonzalez L,  Tablada
M, Robledo CW.  Infostat - Sofware estadístico. Argentina: Uni-
versidad Nacional de Córdoba, Argentina. Univ. Nac. Córdoba;
2013.
23. Kapil S, Trent AM, Goyal SM. Excretion and persistence of Bovine
coronavirus in neonatal calves. Arch Virol. 1990;115:127--32.
24. Lai MMC, Perlman S, Anderson LJ. Coronaviridae. In: Fields B,
Knipe N, David M, Howley P, Knipe DM, Howley PM, Griffin DE,
Lamb RA, Martin MA, Roizman B, Straus SE, editors. Fields virol-
ogy. 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott
Williams & Wilkins; 2007. p. 1305--35 [chapter 36].
25. Langpap TJ, Bergeland ME, Reed DE. Coronaviral enteri-
tis of  young calves: virologic and pathologic findings in
naturally occurring infections. Am J Vet Res. 1979;40:
1476--8.
26. Lorenzetti E, Leme RA, Ribeiro J, Rodrigues Almeida de
Souza V, Alfieri AF, Alfieri AA. Neonatal diarrhea by  Bovine
coronavirus (BCoV) in beef cattle herds. Semin Ciênc Agrár.
2013;34:3795--800.
27. Marsolais G, Assaf R,  Montpetit C, Marois P. Diagnosis of viral
agents associated with neonatal calf diarrhea. Can J Comp Med.
1978;42:168--71.
28. Mawatari T,  Hirano K, Ikeda H, Tsunemitsu H, Suzuki T. Surveil-
lance of diarrhea-causing pathogens in dairy and beef cows
in Yamagata Prefecture, Japan from 2002 to 2011. Microbiol
Immunol. 2014;58:530--5.
29. McGuirk SM, Collins M.  Managing the production, storage, and
delivery of  colostrum. Vet Clin North Am Food Anim Pract.
2004;20:593--603.
30. Mebus CA, Stair EL,  Rhodes MB, Twiehaus MJ. Neonatal calf
diarrhea: propagation, attenuation, and characteristics of a
coronavirus-like agent. Am J Vet Res. 1973;34:145--50.
31. Ohlson A, Alenius S, Traven M,  Emanuelson U. A longitudinal
study of  the dynamics of Bovine coronavirus and respiratory syn-
cytial virus infections in dairy herds. Vet J.  2013;197:395--400.
32. Oma VS, Tråvén M,  Alenius S, Myrmel M, Stokstad M.  Bovine coro-
navirus in naturally and experimentally exposed calves; viral
shedding and the potential for transmission. Virol J.  2016:100.
33. Pardon B, Alliet J,  Boone R, Roelandt S, Valgaeren B, Deprez
P. Prediction of  respiratory disease and diarrhea in veal
calves based on immunoglobulin levels and the serostatus
for respiratory pathogens measured at arrival. Prev Vet Med.
2015;120:169--76.
34. Raboisson D, Trillat P, Cahuzac C. Failure of  passive immune
transfer in calves: a meta-analysis on the consequences and
assessment of  the economic impact. PLoS One. 2016;11:3.
35. Saif LJ, Redman DR, Brock KV, Kohler EM, Heckert RA. Winter
dysentery in adult dairy cattle: detection of coronavirus in the
faeces. Vet Rec. 1988;123:300--1.
36. Smith DR, Tsunemitsu H, Heckert RA, Saif LJ. Evaluation of  two
antigen-capture ELISAs using polyclonal or monoclonal antibod-
ies for the detection of  Bovine coronavirus. J Vet Diagn Invest.
1996;8:99--105.
37. Stipp DT, Barry AF,  Alfieri AF,  Takiuchi E, Amude AM, Alfieri AA.
Frequency of  BCoV detection by a semi-nested PCR assay in
faeces of  calves from Brazilian cattle herds. Trop Anim Health
Prod. 2009;41:1563--7.
38. Vlasova AN, Saif LJ. Biological aspects of  the interspecies trans-
mission of selected coronaviruses. In: Singh SK, editor. Viral
infections and global change. 1st ed. John Wiley &  Sons, Inc.;
2014. p.  393--418 [chapter 21].
39. Weaver DM, Tyler JW, VanMetre DC, Hostetler DE, Barrington
GM. Passive transfer of  colostral immunoglobulins in calves. J
Vet Intern Med. 2000;14:569--77.
Document downloaded from http://www.elsevier.es, day 17/06/2018. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.
